Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05505942 · ClinicalTrials.gov registry record · NA

Physical Activity for PLWH and Unhealthy Drinking

A NA study of HIV and Physical Inactivity, sponsored by Boston University.

Active
Registry status
NA
Development phase
222
Enrollment target
1
Study location

NCT05505942: Active NA study of HIV and Physical Inactivity, sponsored by Boston University.

NCT05505942 is a NA study of HIV and Physical Inactivity that is active but no longer recruiting, run by Boston University. The registered enrollment target is 222 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05505942, a NA study of HIV and Physical Inactivity, is active but no longer recruiting, sponsored by Boston University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
222 participants
Enrollment target
1
Study location

Study Summary

Brief Summary: Alcohol use disorder (AUD) is a significant and costly public health problem that affects one-third of the U.S. population in their lifetime. Specifically, unhealthy alcohol use is common among persons living with HIV (PLWH) and increases the risk of developing negative outcomes. Antiretroviral therapy (ART) has shown increasing life expectancy and decreased HIV-related deaths, leading to a growing older adult HIV population. Yet, HIV accelerates the aging process and increases the risk for numerous chronic health conditions that compromise physical and mental health functioning and quality of life. Thus, PLWH continue to have shorter life expectancies relative to the general population and these multimorbidities explain this increased risk. In this context, unhealthy alcohol use among PLWH can further increase the risk for negative outcomes. Physical activity (PA) interventions can be used as an effective way to address unhealthy alcohol use among PLWH. Previous PA interventions have shown low generalizability and high loss to follow-up. Therefore, an intervention that is home-based, including lifestyle physical activity (LPA) with mobile health-delivered components is designed following the physical activity (PA) paradigm. Participants in this randomized controlled trial will be assigned to one of two study arms -- either the LPA or Fitbit Only intervention - both lasting 12-weeks. Both study arms will utilize a Fitbit to track daily step counts. In addition to utilizing a Fitbit, the LPA arm will receive 7 LPA sessions with a trained interventionist to assist in adding LPA to the participant's routine. The Fitbit only arm will receive only brief check-in phone calls and only related to assisting with any Fitbit functioning issues. Follow-up assessments will take place at 3 and 6 months.

Primary Outcome

Physical activity (PA) will be assessed via steps per day as collected by a participant's Fitbit.

Interventions

  • BEHAVIORAL LPA Sessions
  • OTHER Fitbit Only

Study Locations (1)

Massachusetts

  • Boston University, Department of Medicine, remote research - Boston

Trial Details

FieldValue
Enrollment Target 222 participants
Start Date 2023-02-22
Est. Completion 2026-07
Phase NA
Boston University

185 total trials

What the registry record for NCT05505942 still lists

NCT05505942 is an interventional study that assigns participants to a tested intervention. The registered 222 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (49% lower).

The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which LPA Sessions is the first listed.

NCT05505942 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05505942 about?

NCT05505942 is a clinical study titled "Physical Activity for PLWH and Unhealthy Drinking". Brief Summary: Alcohol use disorder (AUD) is a significant and costly public health problem that affects one-third of the U.S. population in their lifetime. Specifically, unhealthy alcohol use is common among persons living with HIV (PLWH) and increases the risk of developing negative outcomes. Anti...

What is the current status of trial NCT05505942?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 222 participants. The study started on 2023-02-22. Estimated completion is 2026-07.

What conditions does trial NCT05505942 study?

This clinical trial studies the following conditions: HIV, Physical Inactivity, Unhealthy Alcohol Use.

What interventions are being tested in trial NCT05505942?

The interventions under investigation include: LPA Sessions (BEHAVIORAL), Fitbit Only (OTHER).

Who is sponsoring clinical trial NCT05505942?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05505942 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05505942's enrollment target sits among peer trials

222 95th of 303 higher than 209 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04939610 · 222 participants · Phase 1

    A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

  • NCT05424783 · 222 participants

    MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)

  • NCT05568264 · 222 participants · NA

    Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit

  • NCT05605574 · 222 participants · NA

    Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05505942, the US trial registry maintained by the National Library of Medicine. NCT05505942 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.